F. Teixeira-Clerc

发表

Guidelines for the use and interpretation of assays formonitoring autophagy (3rd edition)

Sangeeta Khare, Xin Qi, Ying Wang, 2016 .

The endocannabinoid system as a key mediator during liver diseases: new insights and therapeutic openings

A. Mallat, S. Lotersztajn, V. Deveaux, 2011, British journal of pharmacology.

Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic Steatosis

Andreas Zimmer, Sophie Lotersztajn, Alexandre Louvet, 2009, PloS one.

Cannabinoid signaling and liver therapeutics.

A. Mallat, S. Lotersztajn, F. Teixeira-Clerc, 2013, Journal of hepatology.

Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in mice

A. Mallat, S. Lotersztajn, A. Zimmer, 2011, Hepatology.

Beneficial paracrine effects of cannabinoid receptor 2 on liver injury and regeneration

T. Tordjmann, A. Mallat, S. Lotersztajn, 2010, Hepatology.

CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis

C. Ledent, Liying Li, A. Mallat, 2006, Nature Medicine.

CB2 receptors as new therapeutic targets for liver diseases

A. Mallat, S. Lotersztajn, A. Zimmer, 2008, British journal of pharmacology.

The Cannabinoid Receptor 2 Protects Against Alcoholic Liver Disease Via a Macrophage Autophagy-Dependent Pathway

J. Pawlotsky, S. Lotersztajn, F. Teixeira-Clerc, 2016, Scientific Reports.

The sphingosine 1‐phosphate receptor S1P2 triggers hepatic wound healing

J. Chun, A. Mallat, S. Lotersztajn, 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Chronic Exposure to Low Doses of Dioxin Promotes Liver Fibrosis Development in the C57BL/6J Diet-Induced Obesity Mouse Model

X. Coumoul, R. Barouki, S. Lotersztajn, 2016, Environmental health perspectives.

Macrophage autophagy protects against liver fibrosis in mice

J. Wan, J. Pawlotsky, S. Lotersztajn, 2015, Autophagy.

[CB1 cannabinoid receptor antagonists: a novel approach for the treatment of liver fibrosis].

J. Tran van Nhieu, C. Ledent, Liying Li, 2006, Medecine sciences : M/S.

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

Mark R. Marten, Erinna F. Lee, Dana L. Miller, 2021, Autophagy.

Autophagy: A Multifaceted Partner in Liver Fibrosis

P. Codogno, R. Moreau, A. Mallat, 2014, BioMed research international.

Molecular mechanisms regulating the antifibrogenic protein heme-oxygenase-1 in human hepatic myofibroblasts.

Liying Li, A. Mallat, S. Lotersztajn, 2004, Journal of hepatology.

Small-molecule inhibitors of cyclophilins block opening of the mitochondrial 1 permeability transition pore and protect mice from hepatic ischemia – reperfusion injury 2 3

Jean-François, J. Pawlotsky, J. Calderaro, 2022 .

A cysteine-linkable, short cleavable photoprobe with dual functionality to explore protein-protein interfaces.

A. Ménez, P. Kessler, F. Teixeira-Clerc, 2003, Bioconjugate chemistry.

M2 Kupffer cells promote M1 Kupffer cell apoptosis: A protective mechanism against alcoholic and nonalcoholic fatty liver disease

Albert Tran, Sophie Lotersztajn, Alexandre Louvet, 2014, Hepatology.

Antifibrogenic role of the cannabinoid receptor CB2 in the liver.

Liying Li, A. Mallat, S. Lotersztajn, 2005, Gastroenterology.

Small-molecule inhibitors of cyclophilins block opening of the mitochondrial permeability transition pore and protect mice from hepatic ischemia-reperfusion injury.

J. Pawlotsky, J. Calderaro, F. Allemand, 2019, Gastroenterology.

Hepatic fibrosis: molecular mechanisms and drug targets.

A. Mallat, S. Lotersztajn, F. Teixeira-Clerc, 2005, Annual review of pharmacology and toxicology.

Tissue damage induces a conserved stress response that initiates quiescent muscle stem cell activation.

T. Voet, J. Pawlotsky, M. Sampaolesi, 2021, Cell stem cell.

Reply:

A. Mallat, S. Lotersztajn, V. Deveaux, 2011 .

Aryl hydrocarbon receptor-dependent induction of liver fibrosis by dioxin.

X. Coumoul, R. Barouki, S. Lotersztajn, 2014, Toxicological sciences : an official journal of the Society of Toxicology.

Cannabinoid receptors as new targets of antifibrosing strategies during chronic liver diseases

A. Mallat, S. Lotersztajn, V. Deveaux, 2007, Expert opinion on therapeutic targets.

How Do Short Neurotoxins Bind to a Muscular-type Nicotinic Acetylcholine Receptor?*

A. Ménez, P. Kessler, F. Teixeira-Clerc, 2002, The Journal of Biological Chemistry.

Macrophage autophagy protects against hepatocellular carcinogenesis in mice

J. Pawlotsky, F. Teixeira-Clerc, A. Thiolat, 2021, Scientific Reports.

Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

Sara W. Bird, Erinna F. Lee, Michael D. Kim, 2016 .

S. Lotersztajn, F. Teixeira-Clerc, 2014 .

Cannabinoid signaling and liver therapeutics.

A. Mallat, S. Lotersztajn, F. Teixeira-Clerc, 2013, Journal of hepatology.

Supplemental Material Chronic Exposure to Low Doses of Dioxin Promotes Liver Fibrosis Development in the C 57 BL 6 / J Diet-Induced Obesity Mouse Model

X. Coumoul, R. Barouki, S. Lotersztajn, 2016 .